Helen is a partner of the firm’s Shanghai office. In addition to the New York bar, Helen possesses both Chinese bar and Chinese patent bar qualifications. She holds a master’s degree in bioengineering and an LL.M. from Stanford Law School.
With abundant experience in life sciences and intellectual property practice, Helen frequently advises pharmaceutical, biotechnology, and medical device companies on a variety of regulatory, commercial and intellectual property issues, including clinical trials, drug registration, market entrance, pricing, drug labelling and package, advertising and promotional activities, technology licensing and transfers, enforcement, and industry-specific compliance issues.
Helen was recognised by Chambers & Partners as an “Outstanding Young Partner” in 2014, a “Leading Lawyer for Healthcare” (2015-2018) and a “Leading Lawyer for IP Litigation” (2014-2018). She was also named as a “Highly Recommended Lawyer” for healthycae2018 by Legal 500. Chambers & Partners states that she has "deep professional knowledge and very solid methodology". She is praised by clients for “her business acumen as well as her communication skills and strategic approach” and "her understanding as well as quick and accurate grasp of key points, [which] helped her clients achieve their goals".
Helen is an adjunct professor of the East China University of Politics and Law and the Koguan School of Law, Shanghai Jiaotong University. She has published numerous articles on regulatory development and IP protection in life sciences industry in China in a number of influential periodicals and magazines.